Search hospitals > Georgia > Atlanta
Emory University School of Medicine
Claim this profileAtlanta, Georgia 30322
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Postprandial Fullness Syndrome
Conducts research for Antiretroviral Therapy
Conducts research for Sickle Cell Disease
Conducts research for Contrast-induced Nephropathy
295 reported clinical trials
25 medical researchers
Summary
Emory University School of Medicine is a medical facility located in Atlanta, Georgia. This center is recognized for care of Human Immunodeficiency Virus Infection, Postprandial Fullness Syndrome, Antiretroviral Therapy, Sickle Cell Disease, Contrast-induced Nephropathy and other specialties. Emory University School of Medicine is involved with conducting 295 clinical trials across 469 conditions. There are 25 research doctors associated with this hospital, such as Olatunji Alese, Jane L Meisel, Melinda L. Yushak, and Sagar Lonial, MD.Top PIs
Olatunji AleseEmory University Hospital/Winship Cancer Institute7 years of reported clinical research
Studies Stomach Cancer
Studies Colorectal Cancer
17 reported clinical trials
42 drugs studied
Jane L MeiselWinship Cancer Institute / Emory University School of Medicine1 year of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
11 reported clinical trials
24 drugs studied
Melinda L. YushakEmory University Hospital/Winship Cancer Institute7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
11 reported clinical trials
24 drugs studied
Sagar Lonial, MDThe Winship Cancer Institute of Emory University4 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
10 reported clinical trials
20 drugs studied
Clinical Trials running at Emory University School of Medicine
Amyloidosis
Sickle Cell Disease
Colitis
Stroke
Spinal Cord Injury
Cardiovascular Disease
Prader-Willi Syndrome
Ulcerative Colitis
Postprandial Fullness Syndrome
Cardiomyopathy
NTLA-2001
for ATTR-CM
To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM.
Recruiting1 award Phase 34 criteria
Acoramidis
for Amyloidosis
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different organs in the body and can cause damage to the organ. There are two ways that the TTR protein can fall apart. One way occurs as a person ages, where the normal TTR protein can fall apart and form amyloid that may no longer be sufficiently cleared by the body. This type of ATTR is known as wild-type ATTR (ATTRwt). The other way occurs when a person inherits a defective TTR gene that causes the TTR protein to spontaneously fall apart. This form of the disease is known as variant ATTR (ATTRv) and can be detected in adults by a genetic test of their TTR gene before they age. Amyloid build-up in the heart causes the heart wall to become thick and stiff and can result in heart failure and even death. Accumulation of TTR amyloid in the heart is known as transthyretin amyloid cardiomyopathy or ATTR-CM. Amyloid can also deposit in the nerve tissues leading to nerve problems. Accumulation of TTR in the nerves is known as transthyretin amyloid polyneuropathy or ATTR-PN. Acoramidis is an experimental drug designed to bind tightly to TTR in the blood and stabilize its structure, so it does not form the harmful amyloid plaques that can cause damage to organs. This study is intended to determine if treatment with acoramidis in participants with ATTRv who have not yet developed any symptoms of disease can prevent or delay the development of ATTR-CM or ATTR-PN disease. If adults with an inherited defective TTR gene are treated early before any of the symptoms of disease have developed, it may be possible to delay the onset or prevent the disease entirely.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University School of Medicine?
Emory University School of Medicine is a medical facility located in Atlanta, Georgia. This center is recognized for care of Human Immunodeficiency Virus Infection, Postprandial Fullness Syndrome, Antiretroviral Therapy, Sickle Cell Disease, Contrast-induced Nephropathy and other specialties. Emory University School of Medicine is involved with conducting 295 clinical trials across 469 conditions. There are 25 research doctors associated with this hospital, such as Olatunji Alese, Jane L Meisel, Melinda L. Yushak, and Sagar Lonial, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.